William L. Mitchell - Concepedia

Author

William L. Mitchell

Also Known As

Mitchell, W.L., W L Mitchell, W Mitchell, W. L. MITCHELL, W. L. Mitchell, W. Mitchell, WILLIAM L. MITCHELL, William L Mitchell, William L. Mitchell, William Mitchell

Publications

1.1K

Citations

H-Index

Concepts

All Affiliations

GlaxoSmithKline (United Kingdom)University of Leicester University of Bath GlaxoSmithKline (China)Mount Desert Island Biological Laboratory

About

William L. Mitchell is an author at GlaxoSmithKline (United Kingdom) specializing in engineering, organic chemistry, and medicine.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Engineering	10	11	361
2	Medicine	8	8	283
3	Natural Sciences	5	5	137
4	Biochemistry	5	5	146
5	Health Sciences	2	2	67

William L. Mitchell

Publications

989

Citations

H-Index

Page 1

	Year	Citations
Molybdenum(II)-Catalyzed Allylation of Electron-Rich Aromatics and Heteroaromatics Andrei V. Malkov, Stuart L. Davis, Ian R. Baxendale, The Journal of Organic Chemistry Inorganic ChemistryChemical EngineeringCross-coupling ReactionEngineeringMetal Template-controlled Process	1999	132
Discovery of 2-[(2,4-Dichlorophenyl)amino]- <i>N</i> -[(tetrahydro- 2 <i>H</i> -pyran-4-yl)methyl]-4-(trifluoromethyl)- 5-pyrimidinecarboxamide, a Selective CB2 Receptor Agonist for the Treatment of Inflammatory Pain Gerard M.P. Giblin, Celestine T. O’Shaughnessy, Alan Naylor, Journal of Medicinal Chemistry	2007	120
Development of a Series of Aryl Pyrimidine Kynurenine Monooxygenase Inhibitors as Potential Therapeutic Agents for the Treatment of Huntington’s Disease Leticia Toledo‐Sherman, Michael E. Prime, Ladislav Mrzljak, Journal of Medicinal Chemistry Molecular PharmacologyMedicinal ChemistryNeurodegenerative DiseasesHuntington ’Potential Therapeutic Agents	2015	61
2,8′-Disubstituted-1,1′-Binaphthyls: A New Pattern in Chiral Ligands Štěpán Vyskočil, L. Meca, I. Tišlerová, Chemistry - A European Journal Asymmetric CatalysisEngineeringNew PatternTitle Binaphthyls 19Organic Chemistry	2002	60
Discovery of 1-[4-(3-Chlorophenylamino)-1-methyl-1<i>H</i>-pyrrolo[3,2-<i>c</i>]pyridin-7-yl]-1-morpholin-4-ylmethanone (GSK554418A), a Brain Penetrant 5-Azaindole CB<sub>2</sub>Agonist for the Treatment of Chronic Pain Gerard M.P. Giblin, Andrew Billinton, Michael A. Briggs, Journal of Medicinal Chemistry	2009	53
Electrocardiogram of the Diving Seal H. V. Murdaugh, James C. Seabury, William L. Mitchell Circulation Research Electrophysiological EvaluationDrowningVagal StimulusPhysiologyNormal Dive	1961	50
Cessation of renal function during diving in the trained seal (<i>Phoca vitulina</i>) H. V. Murdaugh, Bodil Schmidt‐Nielsen, JohnF. Wood, Journal of Cellular and Comparative Physiology Trained SealUrologyRenal FunctionSodium HomeostasisMedicine	1961	46
Enantiopure Pseudo-<i>C</i><sub>3</sub>-Symmetric Titanium Alkoxide with Propeller-Like Chirality Philip Axe, Steven D. Bull, Matthew G. Davidson, Organic Letters	2006	46
Synthesis and evaluation of 3-amino-6-aryl-pyridazines as selective CB2 agonists for the treatment of inflammatory pain Robert J. Gleave, Paul Beswick, Andrew J. Brown, Bioorganic & Medicinal Chemistry Letters Molecular PharmacologyMedicinal ChemistryAnti-inflammatoryHealth SciencesInflammatory Pain	2009	44
An enantiopure pseudo-C3-symmetric titanium triflate with propeller-like chirality as a catalyst for asymmetric sulfoxidation reactions Philip Axe, Steven D. Bull, Matthew G. Davidson, Dalton Transactions	2009	31

Page 1